Asset Details
Do you wish to reserve the book?
Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells
Do you wish to request the book?
Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells
2021
Overview
Leukemia stem cells (LSCs) promote the disease and seem resistant to therapy and immune control. Why LSCs are selectively resistant against elimination by CD8+ cytotoxic T cells (CTLs) is still unknown. In this study, we demonstrate that LSCs in chronic myeloid leukemia (CML) can be recognized and killed by CD8+ CTLs in vitro. However, Tregs, which preferentially localized close to CD8+ CTLs in CML BM, protected LSCs from MHC class I-dependent CD8+ CTL-mediated elimination in vivo. BM Tregs in CML were characterized by the selective expression of tumor necrosis factor receptor 4 (Tnfrsf4). Stimulation of Tnfrsf4 signaling did not deplete Tregs but reduced the capacity of Tregs to protect LSCs from CD8+ CTL-mediated killing. In the BM of newly diagnosed CML patients, TNFRSF4 mRNA levels were significantly increased and correlated with the expression of the Treg-restricted transcription factor FOXP3. Overall, these results identify Tregs as key regulators of immune escape of LSCs and TNFRSF4 as a potential target to reduce the function of Tregs and boost antileukemic immunity in CML.
Publisher
American Society for Clinical Investigation,American Society for Clinical investigation
Subject
/ Antigens
/ Female
/ Humans
/ Kinases
/ Leukemia
/ Leukemia, Myelogenous, Chronic, BCR-ABL Positive - immunology
/ Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology
/ Major histocompatibility complex
/ Male
/ Mice
/ Proteins
/ Receptors, OX40 - metabolism
